Cargando…
Glial Cell Line-Derived Neurotrophic Factor-Transfected Placenta-Derived Versus Bone Marrow-Derived Mesenchymal Cells for Treating Spinal Cord Injury
BACKGROUND: Placenta-derived mesenchymal stem cells (PMSCs) were isolated from placenta and had differentiation and self-renewal potential. We transfected PMSCs with glial cell line-derived neurotrophic factor (GDNF) and compared their effect for repairing spinal cord injury (SCI) with that of GDNF-...
Autores principales: | Lu, Yao, Gao, Hui, Zhang, Man, Chen, Bing, Yang, Huilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400030/ https://www.ncbi.nlm.nih.gov/pubmed/28408732 http://dx.doi.org/10.12659/MSM.902754 |
Ejemplares similares
-
Brain Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor-Transfected Bone Mesenchymal Stem Cells for the Repair of Periphery Nerve Injury
por: Zhang, Qiang, et al.
Publicado: (2020) -
Transfection of the glial cell line-derived neurotrophic factor gene promotes neuronal differentiation
por: Du, Jie, et al.
Publicado: (2014) -
Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury
por: Ortmann, Stephen D., et al.
Publicado: (2018) -
History of Glial Cell Line-Derived Neurotrophic Factor (GDNF) and Its Use for Spinal Cord Injury Repair
por: Walker, Melissa J., et al.
Publicado: (2018) -
Bone marrow-derived mesenchymal stem cells differentiate into nerve-like cells in vitro after transfection with brain-derived neurotrophic factor gene
por: Liu, Qianxu, et al.
Publicado: (2015)